Standard BioTools Inc. (LAB)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Proteomics	135.79M	63.88M	52.50M	67.66M	-
Proteomics Growth	112.56%	21.68%	-22.40%	-	-
Genomics	38.64M	42.46M	45.45M	62.92M	-
Genomics Growth	-8.98%	-6.58%	-27.78%	-	-
Develops, Manufactures and Commercializes Tools for Life Science Research	-	-	-	-	138.14M
Develops, Manufactures and Commercializes Tools for Life Science Research Growth	-	-	-	-	17.83%
Total	174.43M	106.34M	97.95M	130.58M	138.14M
Total Growth	64.03%	8.57%	-24.99%	-5.47%	17.83%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Europe, Middle East and Africa (EMEA)	52.32M	36.20M	33.14M	42.72M	37.78M
Europe, Middle East and Africa (EMEA) Growth	44.52%	9.25%	-22.44%	13.09%	-5.62%
Americas Excl. United States	3.56M	2.10M	2.98M	3.68M	2.59M
Americas Excl. United States Growth	69.94%	-29.71%	-18.90%	42.19%	-28.48%
Asia-Pacific (Excl. China)	16.85M	7.99M	10.06M	11.48M	14.68M
Asia-Pacific (Excl. China) Growth	110.85%	-20.52%	-12.42%	-21.80%	-0.82%
United States	89.90M	44.10M	41.00M	60.20M	72.00M
United States Growth	103.85%	7.56%	-31.89%	-16.39%	65.90%
China	11.80M	15.95M	10.77M	12.50M	11.10M
China Growth	-26.02%	48.05%	-13.81%	12.61%	-27.92%
Total	174.43M	106.34M	97.95M	130.58M	138.14M
Total Growth	64.03%	8.57%	-24.99%	-5.47%	17.83%

Source: S&P Global Market Intelligence.